Astra To Continue Pulmicort Manufacturing Talks With FDA

Astra is in discussions with FDA regarding "restrictive manufacturing specifications" applying to the firm's dry powder inhaled asthma therapy Pulmicort Turbuhaler, the company said.

More from Archive

More from Pink Sheet